Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2015 2
2016 9
2017 12
2018 12
2019 5
2020 10
2021 14
2022 22
2023 24
2024 25
2025 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions.
Rashedi S, Leyva H, Hamade N, Pfeferman MB, Ortega-Paz L, Sadeghipour P, Talasaz AH, O'Donoghue ML, Jimenez D, Monreal M, Anderson CD, Elkind MSV, Lang IM, Weitz JI, Goldhaber SZ, De Caterina R, Konstantinides SV, Piazza G, Krumholz HM, Braunwald E, Bikdeli B. Rashedi S, et al. Among authors: ortega paz l. J Am Coll Cardiol. 2025 Oct 7;86(14):1065-1087. doi: 10.1016/j.jacc.2025.07.061. J Am Coll Cardiol. 2025. PMID: 41033744 Review.
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
Galli M, Benenati S, Laudani C, Simeone B, Sarto G, Ortega-Paz L, Rocco E, Bernardi M, Spadafora L, D'Amario D, Greco E, Frati G, Federici M, Mehran R, Crea F, Angiolillo DJ, Sciarretta S. Galli M, et al. Among authors: ortega paz l. J Am Coll Cardiol. 2025 Nov 18;86(20):1805-1819. doi: 10.1016/j.jacc.2025.08.027. Epub 2025 Aug 27. J Am Coll Cardiol. 2025. PMID: 40892610 Free article.
Switching Platelet P2Y12 Receptor Inhibiting Therapies.
Ortega-Paz L, Rollini F, Franchi F, Sibbing D, Angiolillo DJ. Ortega-Paz L, et al. Interv Cardiol Clin. 2024 Oct;13(4S):e1-e30. doi: 10.1016/j.iccl.2024.11.001. Epub 2024 Dec 4. Interv Cardiol Clin. 2024. PMID: 39674676 Review.
Clinical Pharmacokinetics and Pharmacodynamics of CSL112.
Ortega-Paz L, Giordano S, Capodanno D, Mehran R, Gibson CM, Angiolillo DJ. Ortega-Paz L, et al. Clin Pharmacokinet. 2023 Apr;62(4):541-558. doi: 10.1007/s40262-023-01224-8. Epub 2023 Mar 16. Clin Pharmacokinet. 2023. PMID: 36928983 Free PMC article. Review.
Bivalirudin in acute coronary syndromes.
Galli M, Bernardi M, Ortega-Paz L, Nerla R, D'Amario D, Franchi F, Biondi-Zoccai G, Angiolillo DJ. Galli M, et al. Among authors: ortega paz l. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(12):901-911. doi: 10.1080/14779072.2023.2273902. Epub 2023 Dec 13. Expert Rev Cardiovasc Ther. 2023. PMID: 37919937
Acute pulmonary embolism: a multimarker calculator to predict short-term outcomes.
Jiménez D, Dubois-Silva Á, Demelo-Rodríguez P, Ruiz-Artacho P, López-Núñez JJ, Moisés J, Muriel A, Bura-Riviere A, Mahé I, Barillari G, Bikdeli B, Monreal M; RIETE Investigators. Jiménez D, et al. Eur Heart J. 2025 Dec 1;46(45):4921-4929. doi: 10.1093/eurheartj/ehaf228. Eur Heart J. 2025. PMID: 40391731
Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".
Ortega-Paz L, Brugaletta S, Gómez-Lara J, Sabaté M. Ortega-Paz L, et al. Circulation. 2020 Apr 14;141(15):e748-e749. doi: 10.1161/CIRCULATIONAHA.120.045964. Epub 2020 Apr 13. Circulation. 2020. PMID: 32282250 No abstract available.
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis.
Galli M, Occhipinti G, Benenati S, Laborante R, Ortega-Paz L, Franchi F, D'Amario D, Nerla R, Castriota F, Frati G, Biondi-Zoccai G, Sciarretta S, Angiolillo DJ. Galli M, et al. Among authors: ortega paz l. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):526-536. doi: 10.1093/ehjcvp/pvae036. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38754988
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.
Talasaz AH, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom JW, Siegal DM, Monreal M, Jimenez D, Vaduganathan M, Castellucci LA, Cuker A, Barnes GD, Connors JM, Secemsky EA, Van Tassell BW, De Caterina R, Kurlander JE, Aminian A, Piazza G, Goldhaber SZ, Moores L, Middeldorp S, Kirtane AJ, Elkind MSV, Angiolillo DJ, Konstantinides S, Lip GYH, Stone GW, Cushman M, Krumholz HM, Mehran R, Bhatt DL, Bikdeli B. Talasaz AH, et al. Among authors: ortega paz l. Nat Rev Cardiol. 2024 Aug;21(8):574-592. doi: 10.1038/s41569-024-01003-3. Epub 2024 Mar 20. Nat Rev Cardiol. 2024. PMID: 38509244 Review.
144 results